Stephen Gordon - Jun 3, 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon
Stock symbol
TMDX
Transactions as of
Jun 3, 2024
Transactions value $
-$200,788
Form type
4
Date filed
6/5/2024, 05:12 PM
Previous filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $79.2K +2.06K +9.67% $38.46 23.4K Jun 3, 2024 Direct F1
transaction TMDX Common Stock Sale -$280K -2.06K -8.82% $135.93 21.3K Jun 3, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -2.06K -11.79% $0.00 15.4K Jun 3, 2024 Common Stock 2.06K $38.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.